EFFECTS OF INTRAVENOUS DEXMEDETOMIDINE ON 0.5% HYPERBARIC BUPIVACAINE SPINAL ANAESTHESIA FOR INFRAUMBILICAL SURGERIES

Volume 20 No 9 (2022)

Dr. T.V.V.S.V. Prasad, Dr. Ranganadh Timminaina, Dr. Kakani Janakibabu, Dr. Venkata Harini.S, Dr. M. Indira

DOI: 10.14704/nq.2022.20.9.NQ44563

Abstract

Bupivacaine is a pipecoloxylidide derivative developed by Ekenstam in 1957 and first utilized in clinical practice in 1963. It is a racemic mixture of the D and L isomers. (2) (3) Bupivacaine is used for procedures that last 2 to 2.5 hours. For longer procedures it may be necessary to convert to general anaesthesia or augment with an intravenous anaesthetic drug.

Keywords

Bupivacaine, dexmedetomidine, spinal anaesthesia

Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.